Price
No data yet.
Social Signal Score
Analyst Ratings
12 analystsRevenue
$708.60M+115.57%Company Profile
- CEO
- Thomas Harty
- Sector
- Communication Services
- Industry
- Publishing
- Employees
- 5,050
- Beta
- 0.00
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 1.42
Financials
Revenue
$708.60M+115.6%Net Income
$24.80M-21.5%EBITDA
$110.00M+68.6%Free Cash Flow
$34.50M-34.5%EPS (diluted)
$0.27-22.9%Shares Outstanding (diluted)
92.60M+2.8%Operating Expenses
$319.00MCash & Debt
$269.00MReturn of Capital
$8.50MRevenue by Segment (annual)
$5.95BDividend per Share
$0.59Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2021 | $2.98B | $306.60M | $3.35 |
| 2020 | $2.85B | $-234.30M | $-2.56 |
| 2019 | $3.19B | $129.10M | $1.42 |
| 2018 | $2.25B | $99.40M | $1.09 |
| 2017 | $1.71B | $188.93M | $2.12 |
| 2016 | $1.65B | $33.94M | $0.38 |
| 2015 | $1.59B | $136.79M | $1.54 |
| 2014 | $1.47B | $113.54M | $1.27 |
| 2013 | $1.47B | $123.65M | $1.39 |
| 2012 | $1.38B | $104.37M | $1.16 |
| 2011 | $1.40B | $127.43M | $1.40 |
| 2010 | $1.39B | $103.96M | $1.15 |
| 2009 | $1.41B | $-107.08M | $-1.19 |
| 2008 | $1.59B | $134.67M | $1.43 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from MDP's reported EPS growth of 6.8% a year over 13 years.
- EPS in 5 years
- $4.66
- Implied price
- $60.59
- Return from $59.07
- 0.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $30.13 — -49.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| -3.2% | -15.4% | -11.9% | -8.9% | -6.3% | -3.9% |
| 1.8% | -11.0% | -7.3% | -4.2% | -1.4% | 1.1% |
| 6.8% | -6.6% | -2.8% | 0.5% | 3.4% | 6.1% |
| 11.8% | -2.2% | 1.8% | 5.2% | 8.3% | 11.0% |
| 16.8% | 2.1% | 6.3% | 9.9% | 13.1% | 16.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (4)
- Newsglobenewswire.com·5d ago·Negative
Unicycive Therapeutics Appoints Meredith Manning to Board of Directors MOUNTAIN VIEW, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the appointment of Meredith Manning, M.B.A., to its Board of Directors.
View source ↗ - Newsetftrends.com·10d ago·Negative
Private Equity Giant MDP Acquiring Marygold Companies The ETF industry has been abuzz with mergers and acquisitions (M&A) activity. Adding to the growing list of M&A deals, Chicago-based private equity firm Madison Dearborn Partners (MDP) entered into a definitive agreement to acquire The Marygold Companies, Inc. (NYSE: MGLD).
View source ↗ - Newsmarketbeat.com·55d ago·Positive
Medexus Pharmaceuticals Q1 Earnings Call Highlights Medexus Pharmaceuticals TSE: MDP reported higher first-quarter fiscal 2027 revenue and adjusted EBITDA, supported by continued growth for GRAFAPEX and a stronger contribution from IXINITY, while management maintained its full-year outlook for the recently launched transplant-conditioning product.
View source ↗ - Newsyoutube.com·59d ago·Negative
Credit Card Balances at Pace with Inflation: Whitney Meredith Whitney, CEO of Meredith Whitney Advisory Group, joins Scarlet Fu and Tom Keene on "Bloomberg Money." They discuss how many Americans are living payday to payday as well as how consumers are utilizing their credit cards.
View source ↗
Earnings
Typical surprise +39.2% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 28$0.86 vs $0.68beat
- Thu, Aug 12$1.11 vs $0.48beat
- Thu, Apr 29$0.53 vs $0.33beat
- Thu, Feb 4$3.13 vs $2.06beat
- Thu, Nov 5$1.04 vs $0.17beat
- Thu, Aug 13$0.14 vs $0.29miss
Estimates and results for MDP via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by MDP officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Sheldon Whitehousesenate · RI · disclosed Aug 26, 2014 (36d later)Sell$15,001 - $50,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.